Can SGLT-2 inhibitors improve cardiovascular outcomes and ensure safety for patients with type 2 diabetes and heart failure in Thailand? A real-world multicentre retrospective cohort studyTanawan Kongmalai, Amarit Tansawet, Oraluck Pattanaprateep, Cholatid Ratanatharathorn, Porntep Amornritvanich, Panu Looareesuwan, Burin Boonwatcharapai, Anon Khunakorncharatphong, Hataikarn Nimitphong, Varalak Srinonprasert, Ammarin Thakkinstian
12 December 2024
Prevalence and characteristics of liver steatosis and fibrosis in type 2 diabetes mellitus (T2DM) patients: a cross-sectional study in populations of eastern ChinaHekai Yu, Xianghui Su, Wenxuan Tao, Weixia Sun, Xiaoyan Zhang, Qing Han, Zhuoxiao Zhao, Yan Zhang, Xiaoqian Chen, Xinliang Liu, Dianrong Jia, Li Fang, Ling Li
12 December 2024
Association among diabetes, cardiovascular disease and mortality in patients hospitalised for COVID-19: an analysis of the American Heart Association COVID-19 CVD RegistryUnjali Gujral, Lauren T Vanasse, Abhinav Goyal, Arshed Quyyumi, Colby Ayers, Sandeep Das, Francisco Pasquel
4 December 2024
Analysing physical activity measures and clustering in patients with type 2 diabetes in secondary care: insights from the DIAbetes and LifEstyle Cohort Twente (DIALECT)—an observational cohort studyNiala den Braber, Miriam M Vollenbroek-Hutten, Kilian D R Kappert, Gozewijn D Laverman
3 December 2024
Home self-management of type 2 diabetes with diabetes technologies in northern France: a focused ethnographic study protocolRomaric Marcilly, Paul Quindroit, Madleen Lemaitre, Anne Vambergue, Eric Avez, Arnaud Bubeck, Coline Hehn, Jean-Baptiste Beuscart, Tamasine C Grimes
2 December 2024
Investigating the effect of verapamil on preservation of beta-cell function in adults with newly diagnosed type 1 diabetes mellitus (Ver-A-T1D): protocol for a randomised, double-blind, placebo-controlled, parallel-group, multicentre trialJulie Wych, Martina Brunner, Rachel Stenson, Piotr Jaroslaw Chmura, Thomas Danne, Adrian Paul Mander, Chantal Mathieu, Colin Dayan, Thomas R Pieber
28 November 2024
Using Artificial Intelligence-informed Experience-Based Co-Design (AI-EBCD) to create a virtual reality-based mindfulness application to reduce diabetes distress: protocol for a mixed-methods feasibility studyShraboni Ghosal, Emma Stanmore, Jackie Sturt, Angeliki Bogosian, David Woodcock, Mengying Zhang, Nicola Milne, Womba Mubita, Glenn Robert, Siobhan O'Connor
28 November 2024
iDiabetes platform—enhanced phenotyping of patients with diabetes for precision diagnosis, prognosis and treatment: study protocol for a cluster-randomised controlled study in Tayside, ScotlandYeunYi Lin, Damien Leith, Michael Abbott, Rachael Barrett, Samira Bell, Tim J Croudace, Scott Cunningham, John Dillon, Peter Donnan, Albert Farre, Rodolfo Hernández, Chim Lang, Stephanie McKenzie, Ify Mordi, Susan MorrowSee the full list of authors
28 November 2024
Association of overweight and obesity with gestational diabetes mellitus among pregnant women attending antenatal care clinics in Addis Ababa, Ethiopia: a case-control studyYeabsra Mesfin Seifu, Negussie Deyessa, Yimer Seid Yimer
27 November 2024
Impact of exercise training in combination with dapagliflozin on physical function in adults with type 2 diabetes mellitus: study protocol for the Dapagliflozin, Exercise Training and physicAl function (DETA) randomised controlled trialJack A Sargeant, Ehtasham Ahmad, Emily James, Luke Baker, Joanna M Bilak, Nicole A Coull, Gaurav Singh Gulsin, James A King, Kamlesh Khunti, Emma Redman, Alex Rowlands, Emma Watson, Joanne V Wormleighton, Gerry P McCann, Thomas YatesSee the full list of authors
25 November 2024
